Virginia Regulatory Town Hall
Department of Health Professions
Board of Pharmacy
Regulations Governing the Practice of Pharmacy [18 VAC 110 ‑ 20]
Action is Exempt from Article 2 of the Administrative Process Act
Scheduling for conformity to DEA scheduling
Action 5518
General Information
Action Summary As specified in § 54.1-3443 (E), the Board has acted to schedule drugs in the Virginia Drug Control Act in accordance with actions of the U. S. Drug Enforcement Act (DEA) “after the expiration of 30 days from publication in the Federal Register of a final or interim final order or rule.” This action will add three chemicals compounds in Schedule I, two in Schedule II, two in Schedule IV, one in Schedule V and will change the name of one drug in Schedule II.
Chapters Affected Only affects this chapter.
Executive Branch Review This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication.
Exempt Citation: § 2.2-4006 (A) (13)
RIS Project Yes  [006327]
New Periodic Review This action will not be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
8952 Final Stage complete. This regulation became effective on 08/05/2020.
Contact Information
Name / Title: Caroline Juran, RPh  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
Email Address:
Phone: (804)367-4456    FAX: (804)527-4472    TDD: ()-

This person is the primary contact for this chapter.